Navigation Links
Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
Date:3/31/2008

SHANGHAI, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, announced today that it will file a Form 12b-25 with the Securities and Exchange Commission (SEC) for a 15-calendar day extension to file its 2007 Annual Report on Form 10-K. The extension is needed to allow additional time to complete the Company's 2007 financial statements for the reasons set forth in the Form 12b-25 filing. The Company intends to complete its financial statements, distribute a press release regarding its financial results for 2007 and file its Form 10-K as soon as possible within the 15- day extension period.

About Linkwell Corporation

Linkwell Corporation develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary Shanghai LiKang Disinfectant High Tech Company ("LiKang"). Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.linkwell.us

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; and effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production, and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Investor Relations

Craig Bird

Segue Ventures LLC

Tel: +1-215-885-4981

Email: chbird@segue.biz


'/>"/>
SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
2. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
3. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
4. The Quantum Group Extends CEOs Employment Agreement
5. CVS/pharmacy and the National Council on Aging Extend Prescription for Better Health Partnership
6. Hands on Disaster Response Extends Cyclone Relief Project
7. Sunrise Announces NYSE Deadline Extended
8. PROGNOSIS Extends its Popular IP Telephony Management Software to Support Nortel Environments
9. Deadline Extended for Essay Submissions to the FSDDS Sun Defense Essay Contest Throughout Florida Elementary Schools
10. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
11. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... for Telehealth, Inc. has received a three-year grant totaling $975,000, renewing its funding ... of Health and Human Services. , This funding marks, the fourth time the ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the leading provider of ... world, is excited to announce Andrew Ly as the winner of the LabRoots Summer ... costs. , Ly, who is in his third year at the University of ...
(Date:8/16/2017)... ... , ... With a new PD diagnosis every nine minutes, research is critical ... are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board ... in all areas relevant to PD research. The SAB meets annually to review ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve ... his tenure, Paul has served us in multiple leadership roles ... Pharmacy in Jun. 2015 and has provided decisive, strategic leadership ...
(Date:8/7/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... known U.S. mesh product liability claims and that it ... U.S. claims at reasonable values. Under the agreements, Endo ... of 2017 and continuing through the fourth quarter of ... the Company intends to increase its mesh product liability ...
(Date:8/4/2017)... 2017  Agragen, LLC, a Cincinnati ... biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces a ... drug candidates, AGR131.  This drug is designed to ... blood of patients suffering from inflammatory conditions such ... Biological pharmaceuticals ...
Breaking Medicine Technology: